Serveur d'exploration sur la rapamycine et les champignons - Exploration (Accueil)

Index « KwdFr.i » - entrée « Association de médicaments (MeSH) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Assemblage viral (MeSH) < Association de médicaments (MeSH) < Association de médicaments (méthodes)  Facettes :

List of bibliographic references indexed by Association de médicaments (MeSH)

Number of relevant bibliographic references: 36.
[0-20] [0 - 20][0 - 36][20-35][20-40]
Ident.Authors (with country if any)Title
000098 (2020) Rami Bou Khalil [Liban]Lithium chloride combination with rapamycin for the treatment of COVID-19 pneumonia.
000227 (2019) Di Dem Özer Etik [Turquie] ; Nuretdin Suna ; Serkan Öcal ; Haldun Selçuk ; Ülkü Da L ; Turan Çolak ; Fatih Hilmio Lu ; Ahmet Sedat Boyac O Lu ; Mehmet HaberalSuccessful Treatment With Direct-Acting Antiviral Agents of Hepatitis C in Patients With End-Stage Renal Disease and Kidney Transplant Recipients.
000241 (2019) Helio Tedesco-Silva [Brésil] ; Julio Pascual [Espagne] ; Ondrej Viklicky [République tchèque] ; Nikolina Basic-Jukic [Croatie] ; Elisabeth Cassuto [France] ; Dean Y. Kim [États-Unis] ; Josep M. Cruzado [Espagne] ; Claudia Sommerer [Allemagne] ; Mohamed Adel Bakr [Égypte] ; Valter D. Garcia [Brésil] ; Huynh-Do Uyen [Suisse] ; Graeme Russ [Australie] ; Myoung Soo Kim [Corée du Sud] ; Dirk Kuypers [Belgique] ; Matthias Buchler [France] ; Franco Citterio [Italie] ; Maria Pilar Hernandez Gutierrez [Suisse] ; Peter Bernhardt [Suisse] ; Steve Chadban [Australie]Safety of Everolimus With Reduced Calcineurin Inhibitor Exposure in De Novo Kidney Transplants: An Analysis From the Randomized TRANSFORM Study.
000260 (2019) Avinash K. Shetty [États-Unis]Pneumocystis jirovecii pneumonia: A potential complication of sirolimus therapy.
000350 (2019) Tong-Wei Guan [République populaire de Chine] ; Yi-Jin Lin [République populaire de Chine] ; Meng-Ying Ou [République populaire de Chine] ; Ke-Bao Chen [République populaire de Chine]Efficacy and safety of everolimus treatment on liver transplant recipients: A meta-analysis.
000446 (2018) David S. Hui [Hong Kong] ; Nelson Lee [Canada] ; Paul K. Chan [Hong Kong] ; John H. Beigel [États-Unis]The role of adjuvant immunomodulatory agents for treatment of severe influenza.
000474 (2018) Heng-Jia Liu [États-Unis] ; Patrick H. Lizotte [États-Unis] ; Heng Du [États-Unis] ; Maria C. Speranza [États-Unis] ; Hilaire C. Lam [États-Unis] ; Spencer Vaughan [États-Unis] ; Nicola Alesi [États-Unis] ; Kwok-Kin Wong [États-Unis] ; Gordon J. Freeman [États-Unis] ; Arlene H. Sharpe [États-Unis] ; Elizabeth P. Henske [États-Unis]TSC2-deficient tumors have evidence of T cell exhaustion and respond to anti-PD-1/anti-CTLA-4 immunotherapy.
000494 (2018) José A. Del Campo [Espagne] ; Marta García-Valdecasas [Espagne] ; Antonio Gil-G Mez [Espagne] ; Ángela Rojas [Espagne] ; Paloma Gallego [Espagne] ; Javier Ampuero [Espagne] ; Rocío Gallego-Durán [Espagne] ; Helena Pastor [Espagne] ; Lourdes Grande [Espagne] ; Francisco J. Padillo [Espagne] ; Jordi Muntané [Espagne] ; Manuel Romero-G Mez [Espagne]Simvastatin and metformin inhibit cell growth in hepatitis C virus infected cells via mTOR increasing PTEN and autophagy.
000679 (2018) Thomas B. Russell ; Emily K. Rinker [États-Unis] ; Claire S. Dillingham ; Laurence B. Givner ; Thomas W. Mclean [États-Unis]Pneumocystis Jirovecii Pneumonia During Sirolimus Therapy for Kaposiform Hemangioendothelioma.
000772 (2017) Erol Demir [Turquie] ; Mehmet Sukru SeverPosttransplant Tuberculosis.
000851 (2017) So-Yeon Jeon [Corée du Sud] ; Ho-Young Yhim [Corée du Sud] ; Na-Ri Lee [Corée du Sud] ; Eun-Kee Song [Corée du Sud] ; Jae-Yong Kwak [Corée du Sud] ; Chang-Yeol Yim [Corée du Sud]Everolimus-induced activation of latent Mycobacterium tuberculosis infection in a patient with metastatic renal cell carcinoma.
000891 (2017) Juli Jaw [Australie] ; Prue Hill [Australie] ; David Goodman [Australie]Combination of Leflunomide and Everolimus for treatment of BK virus nephropathy.
000898 (2017) Johan W. De Fijter [Pays-Bas]Cancer and mTOR Inhibitors in Transplant Recipients.
000901 (2017) Samir G. Mallat ; Bassem Y. Tanios [Liban] ; Houssam S. Itani [Liban] ; Tamara Lotfi ; Ciaran Mcmullan ; Steven Gabardi ; Elie A. Akl [Liban, Canada] ; Jamil R. Azzi [Liban]CMV and BKPyV Infections in Renal Transplant Recipients Receiving an mTOR Inhibitor-Based Regimen Versus a CNI-Based Regimen: A Systematic Review and Meta-Analysis of Randomized, Controlled Trials.
000965 (2016) Paolo Malvezzi ; Thomas Jouve ; Lionel RostaingUse of Everolimus-based Immunosuppression to Decrease Cytomegalovirus Infection After Kidney Transplant.
000C37 (2015) Faouzi Saliba [France] ; Frederik NevensProgression of liver fibrosis in HCV-positive liver transplant recipients randomized to everolimus with reduced calcineurin inhibitor (CNI) therapy or a standard CNI regimen.
000D57 (2015) R Brian Stevens [États-Unis] ; Kirk W. Foster ; Clifford D. Miles ; James T. Lane ; Andre C. Kalil ; Diana F. Florescu ; John P. Sandoz ; Theodore H. Rigley ; Kathleen J. Nielsen ; Jill Y. Skorupa ; Anna M. Kellogg ; Tamer Malik ; Lucile E. WrenshallA randomized 2×2 factorial trial, part 1: single-dose rabbit antithymocyte globulin induction may improve renal transplantation outcomes.
000E63 (2014) Takayoshi Shirasaki [Japon] ; Masao Honda ; Tetsuro Shimakami ; Kazuhisa Murai ; Takayuki Shiomoto ; Hikari Okada ; Riuta Takabatake ; Akihiro Tokumaru ; Yoshio Sakai ; Taro Yamashita ; Stanley M. Lemon ; Seishi Murakami ; Shuichi KanekoImpaired interferon signaling in chronic hepatitis C patients with advanced fibrosis via the transforming growth factor beta signaling pathway.
000F28 (2014) Medhat Abdel Halim [Koweït] ; Torki Al-Otaibi ; Osama Gheith ; Zakaria Zkaria ; Ahmed Mosaad ; Tarek Said ; Prasad Nair ; Narayanan NampooryActive management versus minimization of immunosuppressives of BK virus-associated nephropathy after a kidney transplant.
001057 (2013) Jacqueline G. O'Leary ; Gregory J. Mckenna ; Göran B. Klintmalm ; Gary L. DavisEffect of telaprevir on the pharmacokinetics of sirolimus in liver transplant recipients.
001117 (2012) Teruhiko Imamura [Japon] ; Taro Shiga ; Koichiro Kinugawa ; Naoko Kato ; Miyoko Endo ; Toshiro Inaba ; Hisataka Maki ; Masaru Hatano ; Atsushi Yao ; Yasunobu Hirata ; Ryozo NagaiSuccessful conversion to everolimus after cytomegalovirus infection in a heart transplant recipient.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/RapamycinFungusV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i -k "Association de médicaments (MeSH)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i  \
                -Sk "Association de médicaments (MeSH)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    RapamycinFungusV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdFr.i
   |clé=    Association de médicaments (MeSH)
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Thu Nov 19 21:55:41 2020. Site generation: Thu Nov 19 22:00:39 2020